| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 06/21/2006 | EP1341779B1 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP1146037B1 Process for the preparation of optically active amino alcohols |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791600A Benzothiazole derivatives as adenosine receptor ligands |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791409A (3-{3-' (2,4-bis- trifluormethyl -benzyl)-(5 -ethyl-pyrimidin -2-yl)- amino! -propoxy} -phenyl) -acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 06/21/2006 | CN1791405A Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2a receptor |
| 06/21/2006 | CN1789253A Benzothiazole derivatives synthesis and sterilization property thereof |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/20/2006 | US7064216 Condensation reagents and a process for their preparation |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7064128 Preferentially substituted calcium channel blockers |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | CA2293361C Process for producing 2-hydroxybenzamide derivatives |
| 06/15/2006 | WO2006062580A1 Indane amides with antiproliferative activity |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006061215A2 2-alkyl-cycloalk(en)yl-carboxamides |
| 06/15/2006 | WO2006061135A1 Phenyl-piperazin methanone derivatives |
| 06/15/2006 | WO2006044775A3 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| 06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
| 06/15/2006 | US20060128770 Thiazole derivatives |
| 06/15/2006 | US20060128769 Thiazoyl biphenyl amides |
| 06/15/2006 | US20060128754 tubulysin derivatives used as antitumor agents |
| 06/15/2006 | US20060128670 Pesticidally active ketone and oxime derivatives |
| 06/15/2006 | US20060128662 Novel compounds for treatment of obesity |
| 06/15/2006 | US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors |
| 06/15/2006 | US20060128559 Transition metal catalysts for (co) polymerizing of olefinic monomers |
| 06/15/2006 | CA2590220A1 2-alkyl-cycloalk(en)yl-carboxamides |
| 06/15/2006 | CA2589192A1 Phenyl-piperazin methanone derivatives |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | CA2584307A1 Indane amides with antiproliferative activity |
| 06/14/2006 | EP1669352A1 Thiazoline derivative and use of the same |
| 06/14/2006 | EP1669351A2 Method for preserving quaternary ammonium salt |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1669070A2 2-imino-thiazolidine and -oxazolidine derivatives for use as antiinflammatory agents |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1787822A Compouds and uses thereof in modulating amyloid beta |
| 06/14/2006 | CN1786003A Sulfur, nitrogen heterocyclic naphacyl imine cell compounds and its application in tumour cell |
| 06/14/2006 | CN1785981A N-substituted phenyl-2-oxo-1, 3-thiazolidine-3-formamide derirative, preparation method and its use |
| 06/14/2006 | CN1259312C Compound of substituted benzo heterocyclic by electrophosphorescence |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | USRE39132 Thiazoline acid derivatives |
| 06/13/2006 | USRE39127 Heterocyclic compounds |
| 06/13/2006 | US7060817 Sulfonamide anions as catalysts for NCO oligomerization |
| 06/13/2006 | US7060719 Glutaminyl based DPIV inhibitors |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | WO2006058923A1 Heteroaromatic glucokinase activators |
| 06/08/2006 | WO2006058905A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY |
| 06/08/2006 | WO2006058700A1 Acetamide compounds as fungicides |
| 06/08/2006 | WO2006031566A3 Halogenated benzamide derivatives |
| 06/08/2006 | WO2006028972A3 Mercaptoamides as histone deacetylase inhibitors |
| 06/08/2006 | WO2005107464A3 Compounds and compositions as cathepsin s inhibitors |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122243 Antiallergic |
| 06/08/2006 | US20060122241 Novel macrocycles for the treatment of cancer diseases |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122229 4,5-diarylthiazole derivatives as cb-1 ligands |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 06/08/2006 | US20060122181 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060121546 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 06/08/2006 | CA2590720A1 Heteroaromatic glucokinase activators |
| 06/08/2006 | CA2589010A1 Biaryloxymethylarene carboxylic acids |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | CA2588517A1 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
| 06/08/2006 | CA2558647A1 Insecticidal n-substituted sulfoximines |
| 06/07/2006 | EP1666472A1 Phenylacetic acid derivative, process for producing the same, and use |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1664006A2 Modulators of atp-binding cassette transporters |
| 06/07/2006 | EP1664005A1 Thiazole derivatives as cannabinoid receptor modulators |
| 06/07/2006 | EP1664002A1 Organic compounds |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
| 06/07/2006 | EP1663936A1 Biaryloxymethylarene-carboxylic acids |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | CN1784392A Benzothiazole derivative compounds,compositions and uses |
| 06/07/2006 | CN1781917A Synthetic process for rubber vulcanization accelerator N-tertiary butyl bi (2-benzothiazole) sulfenimide |
| 06/07/2006 | CN1781916A Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/06/2006 | US7057054 Hexafluorocyclopentene di-substituted with an alkoxy- and aryl-substituted furan and/or thiophene; e.g., 1,2-bis(2-methoxy-5-phenyl-3-thienyl)hexafluorocyclopentene; nonfading |
| 06/06/2006 | US7056939 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3) |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/06/2006 | CA2232913C Process for the preparation of azide derivatives |
| 06/06/2006 | CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/06/2006 | CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives |
| 06/06/2006 | CA2154572C Use of riluzole for the treatment of neuro-sida |
| 06/01/2006 | WO2006057448A1 Arylalkanoic acid derivative |
| 06/01/2006 | WO2006056471A1 5-hydroxy-benzothiazole derivatives having beta-2-adrenorecptor agonist activity |
| 06/01/2006 | WO2006056333A1 Substituted oxyguanidines |